CEIV 2.0 Phase 1: Evaluation
Project Purpose
Following the first project (CEIV 1.0), Pharma.Aero initiated a follow-up project (CEIV 2.0) to evaluate how CEIV Pharma certified companies perceive the impact of being CEIV certified on their daily business and the value that the certification has brought. Furthermore, Pharma.Aero involved their strategic pharma shipper members in evaluating the current CEIV Pharma programme and its impact on their air supply chain requirements.
Project CEIV 2.0 started in September 2021 with the first Phase of the project: the evaluation (identifying the challenges, root causes and suggest potential solutions). Pharma.Aero members and project participants designed and prepared Phase 2 of the project: the implementation (advise on how to implement some of the suggested potential solutions.
This page will focus on Phase 1 of the CEIV 2.0 Project.
Project Objective(s)
The aim is to obtain the latest industry view on CEIV Pharma and be able to share the recommendations with IATA to raise awareness of the program and engage shippers in the value of CEIV which should aid them in lane assessment, reduction in audit frequency and complexities.
Project Status And Key-takeaways
Project ongoing, following the steps:
-
Work Package 1: Host and exclusive webinar for the members of both organisations (Pharma.Aero and HLA) on June 15, 2021, followed by a survey. The results of the survey and insights gathered amongst the presenters, the attendees and the project group were outlined in a White Paper. This first report examined the competitive positioning of UAV against other transportation modes, the regulatory framework for drone operations and applications of UAV in the Pharma and Humanitarian Air Cargo sector.
-
Work Package 2: Create a 360° interactive video to showcase drone lab technologies, different types of drones and drone operations. This video is now available for Pharma.Aero members only.
-
Work Package 3: Map the journey of the Covid-19 vaccines from the manufacture point in Europe to the arm of the patient in Malawi. Draft a list of recommendations on how to optimize the end-to-end transportation by shortening the supply chain and linking both traditional airfreight and drone worlds. Disseminate a theoretical proof of concept (technical report and white paper). See here the video of the Vaccines transportation from Belgium to Malawi.
PROJECT
SUPPORT AND
COLLABORATION.
- Pharma.Aero Board liaison: Brussels Airport Company and Changi Airport Group
- Project leads: Dnata
- Project members: 38 members respondents to the survey (WP1), +40 Pharma.Aero members and partners involved in the problem-solving sessions organized in collaboration with IATA (WP3)
- Project expert (Phase 1, WP1): Aynur Rasulova-Rzepa, Rzepa Consulting Limited (external consultant)